Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02204800 · ClinicalTrials.gov registry record
Active Surveillance of the Small Renal Mass
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 4
- Enrollment target
NCT02204800: Completed study, sponsored by Yale University.
NCT02204800 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02204800 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Active surveillance in kidney cancer involves closely observing the tumor with periodic imaging studies rather than immediately proceeding to an invasive treatment. This does not mean that the tumor is ignored or that future treatment is not necessary, rather it means the tumor does not require treatment at this time. On active surveillance, a tumor is closely monitored without treatment, however if the tumor changes and reaches a predefined threshold that your physician no longer considers safe, your physician will strongly encourage treatment.
Primary Outcome
Tumor growth rate is being measured in centimeters/year
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-08-31 |
What the finished NCT02204800 record still lists
NCT02204800 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02204800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02204800 about?
NCT02204800 is a clinical study titled "Active Surveillance of the Small Renal Mass". Active surveillance in kidney cancer involves closely observing the tumor with periodic imaging studies rather than immediately proceeding to an invasive treatment. This does not mean that the tumor is ignored or that future treatment is not necessary, rather it means the tumor does not require trea...
What is the current status of trial NCT02204800?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2014-12. Estimated completion is 2020-08-31.
Who is sponsoring clinical trial NCT02204800?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia